These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 22110205)

  • 1. The role of circulating dendritic cells in patients with unresectable pancreatic cancer.
    Hirooka S; Yanagimoto H; Satoi S; Yamamoto T; Toyokawa H; Yamaki S; Yui R; Inoue K; Michiura T; Kwon AH
    Anticancer Res; 2011 Nov; 31(11):3827-34. PubMed ID: 22110205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating myeloid dendritic cells as prognostic factors in patients with pancreatic cancer who have undergone surgical resection.
    Yamamoto T; Yanagimoto H; Satoi S; Toyokawa H; Yamao J; Kim S; Terakawa N; Takahashi K; Kwon AH
    J Surg Res; 2012 Apr; 173(2):299-308. PubMed ID: 21195425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome of immunotherapy for patients with refractory pancreatic cancer.
    Nakamura M; Wada J; Suzuki H; Tanaka M; Katano M; Morisaki T
    Anticancer Res; 2009 Mar; 29(3):831-6. PubMed ID: 19414316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired function of circulating dendritic cells in patients with pancreatic cancer.
    Yanagimoto H; Takai S; Satoi S; Toyokawa H; Takahashi K; Terakawa N; Kwon AH; Kamiyama Y
    Clin Immunol; 2005 Jan; 114(1):52-60. PubMed ID: 15596409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unresectable pancreatic cancer: is a multi-modality approach a promising therapeutical alternative?
    Lygidakis NJ; Dedemati G; Spenzaris N; Theodoropoulou M
    Hepatogastroenterology; 1997; 44(16):1222-8. PubMed ID: 9261631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients.
    Ferrari S; Malugani F; Rovati B; Porta C; Riccardi A; Danova M
    Oncol Rep; 2005 Jul; 14(1):113-20. PubMed ID: 15944777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic resections after chemoradiotherapy for locally advanced ductal adenocarcinoma: analysis of perioperative outcome and survival.
    Massucco P; Capussotti L; Magnino A; Sperti E; Gatti M; Muratore A; Sgotto E; Gabriele P; Aglietta M
    Ann Surg Oncol; 2006 Sep; 13(9):1201-8. PubMed ID: 16955382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of combined therapy in pancreatic cancer with a poor prognosis: analysis of 233 clinical cases].
    Wang Y; Zhao P; Wang CF; Shan Y; Zhao DB; Tian YT; Sun YM; Che X; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(34):2381-5. PubMed ID: 20137689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes.
    Kondo H; Hazama S; Kawaoka T; Yoshino S; Yoshida S; Tokuno K; Takashima M; Ueno T; Hinoda Y; Oka M
    Anticancer Res; 2008; 28(1B):379-87. PubMed ID: 18383873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of MIB-1 index in the prognosis of resectable pancreatic head cancer.
    Shyr YM; Su CH; Li AF; Wu CW; Lui WY
    Hepatogastroenterology; 1999; 46(29):2968-73. PubMed ID: 10576384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting factors for survival of patients with unresectable pancreatic cancer: a management guideline.
    Fujino Y; Suzuki Y; Ajiki T; Tanioka Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2003; 50(49):250-3. PubMed ID: 12630033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after pancreatoduodenectomy for pancreatic adenocarcinoma: is cure possible?
    Schnelldorfer T; Ware AL; Sarr MG; Smyrk TC; Zhang L; Qin R; Gullerud RE; Donohue JH; Nagorney DM; Farnell MB
    Ann Surg; 2008 Mar; 247(3):456-62. PubMed ID: 18376190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Consecutive re-explorations for final resection of initially unresectable pancreatic head carcinoma.
    Lygidakis NJ; Vlachos L; Raptis S; Sgourakis G; Mourikis D; Kehagias D
    Hepatogastroenterology; 1999; 46(28):2229-39. PubMed ID: 10521972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined immunopharmaceutical therapy of patients with unresectable pancreatic carcinoma.
    Lygidakis NJ; Ziras FA; Kyparidou E; Parissis J; Papadopoulou P; Venetsanou B
    Hepatogastroenterology; 1995; 42(6):1039-52. PubMed ID: 8847017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of unresectable locally advanced pancreatic cancer with combined radiotherapy and chemotherapy].
    Jensen HA; Nielsen HO; Jensen JD; Fristrup CW; Nielsen M; Pfeiffer P
    Ugeskr Laeger; 2008 Feb; 170(8):639-41. PubMed ID: 18364156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
    Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
    Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic head carcinoma: is pancreatic resection indicated for patients with stage III pancreatic duct cancer?
    Lygidakis NJ; Papadopoulou P
    Hepatogastroenterology; 1995; 42(5):587-96. PubMed ID: 8751219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment carbohydrate antigen 19-9 level indicates tumor response, early distant metastasis, overall survival, and therapeutic selection in localized and unresectable pancreatic cancer.
    Yoo T; Lee WJ; Woo SM; Kim TH; Han SS; Park SJ; Moon SH; Shin KH; Kim SS; Hong EK; Kim DY; Park JW
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e623-30. PubMed ID: 21600705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
    Schuricht AL; Spitz F; Barbot D; Rosato F
    Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.